Hogy Medical Co.,Ltd.
HGYMF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.30 | -0.92 | 1.50 | -3.89 |
| FCF Yield | 7.65% | 4.77% | 0.06% | 0.04% |
| EV / EBITDA | 8.40 | 7.19 | 11.18 | 12.11 |
| Quality | ||||
| ROIC | 2.20% | 3.04% | 13.98% | 14.69% |
| Gross Margin | 32.25% | 33.41% | 0.29% | 39.73% |
| Cash Conversion Ratio | 3.94 | 2.54 | 2.15 | 1.95 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.13% | 405.82% | 2.21% | -4.32% |
| Free Cash Flow Growth | 44.76% | 7,182.23% | 35.84% | 844.00% |
| Safety | ||||
| Net Debt / EBITDA | -0.94 | -1.27 | 0.85 | 0.96 |
| Interest Coverage | 54.43 | 181.26 | 228.76 | 1,022.50 |
| Efficiency | ||||
| Inventory Turnover | 2.67 | 2.75 | 2.70 | 2.52 |
| Cash Conversion Cycle | 178.02 | 183.94 | -9,513.92 | 5,153.40 |